Drag a card by its title · ⚙ to size, swap or remove

The company

AN2 Therapeutics, Inc.

ANTX · Nasdaq

Health CareBiotechnologyNot moving yet

ANTX stood above a rising 150-day average in 33 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 24.2% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 2
Industry in uptrend: 18% -14 in 4 wk
Insider buys, 12 months: $23K
Insider sales, 12 months: $792K
Officials’ trades on record: 0
Institutions holding: 66 (+15)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 33 of 52 weeks.

21 Apr – 20 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months18

Buyers · sellers1 · 6

Who	Did	Shares	Traded
Robin Shane ReadnourDirector	sold	523at $6.02	9 Sep 2026filed 11 Sep 2026
Robin Shane ReadnourDirector	sold	585at $6.02	9 Sep 2026filed 11 Sep 2026
Robin Shane ReadnourDirector	sold	4,725at $6.02	8 Sep 2026filed 8 Sep 2026
Robin Shane ReadnourDirector	sold	5,294at $6.02	8 Sep 2026filed 8 Sep 2026
Robin Shane ReadnourDirector	sold	2,877at $6.07	3 Sep 2026filed 8 Sep 2026
Robin Shane ReadnourDirector	sold	3,223at $6.07	3 Sep 2026filed 8 Sep 2026
Margaret M. FitzpatrickDirector	bought	2,098at $5.53	1 Sep 2026filed 2 Sep 2026
Sarah Joanne WilliamsPrincipal Accounting Officer	sold	272at $5.53	1 Sep 2026filed 4 Sep 2026
Robin Shane ReadnourDirector	sold	16,696at $6.01	17 Aug 2026filed 19 Aug 2026
Robin Shane ReadnourDirector	sold	18,706at $6.01	17 Aug 2026filed 19 Aug 2026
Joshua M. EizenOfficer	sold	5,945at $4.17	8 Jul 2026filed 10 Jul 2026
Sarah Joanne WilliamsPrincipal Accounting Officer	sold	265at $4.43	29 May 2026filed 2 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders66+15 on the quarter

New · exited28 · 13

Reported value$119.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Vivo Capital, LLCunchanged · filed 14 Aug 2026	3,153,640$15.3M	00.0%
Commodore Capital LPadded · filed 14 Aug 2026	2,933,680$14.2M	+599,967+25.7%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026	2,318,692$11.2M	+96,190+4.3%
BlackRock, Inc.added · filed 7 Aug 2026	1,665,494$8.1M	+1,346,726+422.5%
Spruce Street Capital LPunchanged · filed 13 Aug 2026	1,661,073$8.0M	00.0%
Almitas Capital LLCreduced · filed 17 Aug 2026	1,469,129$7.1M	-10,000−0.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,238,705$6.0M	+227,627+22.5%
ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 2026	1,000,000$4.8M	00.0%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	951,997$4.6M	+796,758+513.2%
Boxer Capital Management, LLCunchanged · filed 14 Aug 2026	749,035$3.6M	00.0%